Best Medical Devices Developer – Scandinavia

Developeration has been acknowledged as the “Best Medical Devices Developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners-list/?award=11481-2021

Gold company

Developeration AB is accepted to the EIT Health Investor Network as a GOLD Company.

Most innovative medical devices developer

Developeration has been acknowledged as the “Most innovative medical devices developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners/developeration-ab/

4.4MSEK invested in Developeration

2020-09-15 ALMI Invest and STOAF, invest in Developeration AB, in total 4,4MSEK. https://stoaf.se/2020/09/15/stoaf-invests-in-developerations-innovative-surgical-device/ 

2.56MSEK in funding

Developeration AB receives 2,56MSEK in funding for product development and clinical investigations from Sthlm Life Scale-Up Program from Region Stockholm, KI Innovations AB and Tillväxtverket. https://newsroom.notified.com/karolinskainnovations-ki-press/posts/pressreleases/stockholmsforetag-med-tillvaxtpotential-delar

Funding from the European Union’s Horizon

Developeration’s novel device PexyEazy for the surgical treatment of haemorrhoids has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement number: 878276, the first phase of SME Instrument, Horizon 2020. https://cordis.europa.eu/project/rcn/225118/factsheet/en

Member of the KI Innovations Incubator programme

Developeration AB become a member of the Karolinska Institutet Innovations incubator programme, DRIVE. https://www.lifesciencesweden.se/article/view/599332/ki_innovations_valjer_ut_bolag http://www.mynewsdesk.com/se/karolinska-institutet-innovations-ab/pressreleases/nu-erbjuder-vi-starkare-stoed-till-innovativa-bolag-inom-life-science-2492287

Funding from Novo

Developeration AB receives funding from Novo nordisk fonden, Exploratory Pre-seed.